Get a Quote | (719) 471-7425

Olivier Blasi

Olivier Blasi, M.S

Olivier Blasi, M.S

Olivier Blasi has been with Colorado Associates in Medical Physics (CAMP) since 2012.  He specializes in therapeutic medical physics and is certified through the American Board of Radiology.

As a Clinical Medical Physicist, Olivier works with various treatment units including, but not limited to, Varian 21EX, Trilogy, and Truebeam Linear Accelerators, Varian Afterloader, Accuray Cyberknife, Tomotherapy, and Pantak Superficial. He has experience with external beam therapies, brachytherapy, HDR planning, prostate seed planting, stereotactic patients, dosimetry review, image fusion and dose accumulation, as well as R&V systems and intraoperative radiotherapy.  As a Radiation Safety Officer, Olivier completes Landauer monitoring, radiation safety training, I-131 treatments, and breast seed localizations.

Olivier completed his Bachelor of Science in Physics and Mathematics at University of Wyoming and his Masters of Science in Medical and Health Physics at Louisiana State University and A&M College in Baton Rouge, Louisiana.  He completed his Clinical Residency at Mary Bird Perkins Cancer Center in Baton Rouge, LA.

Olivier is based in Colorado Springs, Colorado.

Presentations and Publications

Peddada A, Blasi O, White G, Monroe A, Jennings S, Gibbs G. Prevention of needle displacement in multifraction highdoserate prostate brachytherapy: A prospective volumetric analysis and technical considerations. Practical Radiation Oncology . 2014. doi:10.1016/j.prro.2014.11.004.

ASTRO 2012 Annual Meeting, R04 Stereotactic treatments, “A Method to Objectively Evaluate Stereotactic Radiation Surgery (SRS) Treatments of Essential Tremor Patients”, International Journal of Radiation Oncology * Biology * Physics 1 November 2012 (Vol. 84, Issue 3, Supplement, Page S815, DOI: 10.1016/j.ijrobp.2012.07.2181)

“Preliminary comparison of helical tomotherapy and mixed beams of unmodulated electrons and intensity modulated radiation therapy for treating superficial cancers of the parotid gland and nasal cavity”, O. Blasi 1 , J. Fontenot 1 , 2 * , .R Fields 2 , J. Gibbons 1 , 2 and K. Hogstrom 1 , 2 , Radiation Oncology 2011, 6:178. DOI: 10.1186/1748717X6178

AAPM 2009 Annual Meeting, Poster Presentation SUFFT579, “Comparison of helical tomotherapy and mixed beam treatment plans for superficial parotid cancers”